<DOC>
<DOCNO>
EP-0003758
</DOCNO>
<TEXT>
<DATE>
19790905
</DATE>
<IPC-CLASSIFICATIONS>
A61P-25/02 A61P-25/00 C07D-235/00 A61P-9/00 A61P-9/12 A61K-31/4184 C07D-235/26 A61K-31/4164 A61K-31/415 
</IPC-CLASSIFICATIONS>
<TITLE>
etherified hydroxy-benzodiheterocycles and their acid addition salts, process for their preparation and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
ciba geigy agch<sep>ciba-geigy ag<sep>ciba-geigy agklybeckstrasse 1414002 baselch<sep>
</APPLICANT>
<INVENTOR>
jaeggi knut a drch<sep>ostermayer franz drch<sep>schroeter herbert drch<sep>jaeggi, knut a., dr.<sep>ostermayer, franz, dr.<sep>schroeter, herbert, dr.<sep>jaeggi, knut a., dr.general guisan-strasse 44ch-4054 baselch<sep>ostermayer, franz, dr.am hang 5ch-4125 riehench<sep>schröter, herbert, dr.arisdörferstrasse 16ch-4414 füllinsdorfch<sep>
</INVENTOR>
<ABSTRACT>
the present invention relates to etherified hydroxy-benzodiheterocyclic compounds of the formula   <image> in which alk denotes vicinal alkylene containing 2 or 3 carbon atoms and acid addition salts thereof and processes for the manufacture of these compounds and also pharmaceutical formulations containing compounds of the formula or pharmaceutically acceptable acid addition salts.  these new compounds display valuable pharmacological properties, in particular strong and long- lasting, cardio-selective beta-receptor- blocking activity and also alpha- receptor-blocking activity and can be used, e. g. , for the treatment of disorders of the cardiac rhythme and coronary heart diseases and also as hypotensive agents. 
</ABSTRACT>
</TEXT>
</DOC>
